OR WAIT null SECS
January 28, 2021
Annual Bascom Palmer Eye Institute program will spotlight latest advances in neovascular and exudative ocular disease over 2-day event, February 12-13.
Three sessions cover the range from clinical updates for imaging to emerging therapies for non-exudative AMD.
The program features an update on faricimab, plus diabetes, choroiditis, retinitis pigmentosa, and late-breaking reports.
